Kaplan-Meier estimates of survival from causes other than bladder cancer in the non-muscle invasive bladder cancer cohort (NMIBC) by prognostic group compared to their respective matched comparison cohorts with log-rank test of statistical significance and unadjusted hazard ratio (HR) with 95% confidence interval from a Cox proportional hazards model.</p
<p>Kaplan-Meier survival curve for mortality in (A) patients with 24 h-residual urine volume ≥100 ml...
<p>Kaplan-Meier analysis for overall survival (A) and cancer-specific survival (B) in patients with ...
Kaplan-Meier survival curves of oncological outcomes in patients treated with intravesical BCG follo...
Kaplan-Meier estimates of overall survival in the non-muscle invasive bladder cancer cohort (NMIBC) ...
Kaplan-Meier estimates of overall survival and survival for causes other than bladder cancer for the...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection(TUR) of t...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>(A) Total (p<0.001). (B) Upper urinary tract urothelial carcinoma (p<0.001). (C) Urothelial carci...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection (TUR) of ...
<p>Kaplan-Meier curves for recurrence-free survival rates with urinary tract cancer (A), recurrence-...
<p>The 5-year overall survival rate in patients with high SATB1 expression was significantly worse t...
<p>(A) Total (p<0.001). (B) Upper urinary tract urothelial carcinoma (p<0.001). (C) Urothelial carci...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>Kaplan-Meier analysis for overall survival (A) and cancer-specific survival (B) in patients with ...
<p>Kaplan-Meier estimates of survival curves for patients with advanced lung cancer stratified into ...
<p>Kaplan-Meier survival curve for mortality in (A) patients with 24 h-residual urine volume ≥100 ml...
<p>Kaplan-Meier analysis for overall survival (A) and cancer-specific survival (B) in patients with ...
Kaplan-Meier survival curves of oncological outcomes in patients treated with intravesical BCG follo...
Kaplan-Meier estimates of overall survival in the non-muscle invasive bladder cancer cohort (NMIBC) ...
Kaplan-Meier estimates of overall survival and survival for causes other than bladder cancer for the...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection(TUR) of t...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>(A) Total (p<0.001). (B) Upper urinary tract urothelial carcinoma (p<0.001). (C) Urothelial carci...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection (TUR) of ...
<p>Kaplan-Meier curves for recurrence-free survival rates with urinary tract cancer (A), recurrence-...
<p>The 5-year overall survival rate in patients with high SATB1 expression was significantly worse t...
<p>(A) Total (p<0.001). (B) Upper urinary tract urothelial carcinoma (p<0.001). (C) Urothelial carci...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>Kaplan-Meier analysis for overall survival (A) and cancer-specific survival (B) in patients with ...
<p>Kaplan-Meier estimates of survival curves for patients with advanced lung cancer stratified into ...
<p>Kaplan-Meier survival curve for mortality in (A) patients with 24 h-residual urine volume ≥100 ml...
<p>Kaplan-Meier analysis for overall survival (A) and cancer-specific survival (B) in patients with ...
Kaplan-Meier survival curves of oncological outcomes in patients treated with intravesical BCG follo...